BIO-Key International Inc reports results for the quarter ended in December - Earnings Summary

BIO-key International

31/03/2023 15:24

* BIO-Key International Inc  BKYI.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
December. The lone analyst forecast for the quarter was for a
loss of 27 cents per share.
    * Revenue rose 88.1% to $1.76 million from a year ago;
analysts
expected $1.74 million. 
    * BIO-Key International Inc's reported EPS for the quarter
was a
loss of 62 cents​.
    * The mean earnings estimate of analysts had fallen by
about 237.5% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * BIO-Key International Inc shares had risen by 24.2% this
quarter.
    * The company reported a quarterly loss of $5.11 million.
    * Wall Street's median 12-month price target for BIO-Key
International Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 31 at 02:24 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.27          -0.40          Missed
 Sep. 30 2022      -0.16          -0.29          Missed
 Jun. 30 2022      -0.08          -0.21          Missed
 Mar. 31 2022      -0.22          -0.12          Beat